Company Analysis
Sign in

Edgewise Therapeutics, Inc. (EWTX)

Nasdaq: EWTX · Pharmaceutical Preparations · Boulder, CO · filing with the SEC since 2019
Full chart Alerts Compare
Grade5.2
◀ Past 4.9● Present 6.4▶ Future 4.3
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

9 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Edgewise Therapeutics, Inc.’s names, not what it holds today.

Patents granted
9
9 utility, 1976 to Dec 31, 2025
Granted in 2025
5
Against 1 in 2024 and none in 2023
Applications published
23
8 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Organic fine chemistry9
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Edgewise Therapeutics, Inc. its own name
named as the applicant on its applications, in US
0 granted
23 published
EDGEWISE THERAPEUTICS, INC. its own name
US, as the owner printed on each patent
9 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 30, 202512,509,4311,4-dihydroquinazolinone compounds and uses thereofOrganic fine chemistryEDGEWISE THERAPEUTICS, INC.
Oct 21, 202512,448,369Quinolinone amide compounds and uses thereofOrganic fine chemistryEDGEWISE THERAPEUTICS, INC.
Sep 16, 202512,415,794Pyridazinone compounds and uses thereofOrganic fine chemistryEDGEWISE THERAPEUTICS, INC.
Mar 4, 202512,240,833Pyridazinone compounds and uses thereofOrganic fine chemistryEDGEWISE THERAPEUTICS, INC.
Mar 4, 202512,240,831Pyridazinone compounds and uses thereofOrganic fine chemistryEDGEWISE THERAPEUTICS, INC.
Jun 18, 202412,012,395Pyridazinone compounds and uses thereofOrganic fine chemistryEDGEWISE THERAPEUTICS, INC.
Jul 19, 202211,390,606Pyridazinone compounds and uses thereofOrganic fine chemistryEDGEWISE THERAPEUTICS, INC.
Feb 1, 202211,236,065Pyridazinone compounds and uses thereofOrganic fine chemistryEDGEWISE THERAPEUTICS, INC.
Aug 17, 202111,091,464Pyridazinone compounds and uses thereofOrganic fine chemistryEDGEWISE THERAPEUTICS, INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 25, 20252025/0388564METHODS OF MANUFACTURING PYRIDAZINONE COMPOUNDSOrganic fine chemistryEdgewise Therapeutics, Inc.
Dec 25, 20252025/0387392PYRIDAZINONE COMPOSITIONS FOR THE TREATMENT OF NEUROMUSCULAR CONDITIONSPharmaceuticalsEdgewise Therapeutics, Inc.
Nov 27, 20252025/03612131,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOFOrganic fine chemistryEdgewise Therapeutics, Inc.
Nov 6, 20252025/0340526PYRIDAZINONE COMPOUNDS AND USES THEREOFOrganic fine chemistryEdgewise Therapeutics, Inc.
Jul 10, 20252025/0223278PYRIDAZINONE COMPOUNDS AND USES THEREOFOrganic fine chemistryEdgewise Therapeutics, Inc.
May 15, 20252025/01541111,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOFOrganic fine chemistryEdgewise Therapeutics, Inc. · patent 12,509,431 granted from it
Jan 23, 20252025/0026740QUINOLINONE AMIDE COMPOUNDS AND USES THEREOFOrganic fine chemistryEdgewise Therapeutics, Inc. · patent 12,448,369 granted from it
Jan 23, 20252025/0026726QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOFOrganic fine chemistryEdgewise Therapeutics, Inc.
Oct 10, 20242024/0336609PYRIDAZINONE COMPOUNDS AND USES THEREOFPharmaceuticalsEdgewise Therapeutics, Inc.
Jan 25, 20242024/0025879PYRIDAZINONE COMPOUNDS AND USES THEREOFOrganic fine chemistryEdgewise Therapeutics, Inc. · patent 12,240,831 granted from it
What it applied for, 2024 to 2025: Organic fine chemistry 8 · Pharmaceuticals 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton EWTX · research, not advice